Predictive and prognostic impacts of quality of life measurements and biomarker discovery in chemotherapy treated advanced pancreatic cancer patients in Northern Alberta

生活质量测量和生物标志物发现对艾伯塔省北部接受化疗的晚期胰腺癌患者的预测和预后影响

• 批准号: 272936
• 负责人: Kim Christina
• 金额: $ 2万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2013-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=272936&lang=en
• 关键词: Biomarkers; Clinical Epidemiology; Database; Pancreas Cancer; Quality Of Life; Survival

Pancreas cancer is a very lethal cancer. The symptoms, such as a lack of appetite, weight loss, fatigue and abdominal pain, are very vague. Consequently, approximately 80% of people diagnosed with pancreas cancer have widespread and incurable disease at

胰腺癌是一种非常致命的癌症。食欲不振、体重减轻、乏力和腹痛等症状非常模糊。因此，大约80%被诊断患有胰腺癌的人都有广泛的、不治之症。